Tolerability and efficacy of chemotherapy in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.
B. Seruga
No relevant relationships to disclose
A. M. Horgan
No relevant relationships to disclose
G. R. Pond
No relevant relationships to disclose
S. M. H. Alibhai
No relevant relationships to disclose
E. Amir
No relevant relationships to disclose
R. De Wit
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
M. A. Eisenberger
No relevant relationships to disclose
I. Tannock
No relevant relationships to disclose